ANONDITA

Anondita Medicare Share Price

 

 

Start SIP in ANONDITA

Start SIP
Anondita Medicare live price: ₹785. It opened at ₹716 vs previous close ₹735; intraday high/low: ₹785/₹716. The 50 DMA stands at ₹730.66.

Anondita Medicare Performance

  • Today's Low
  • ₹716
  • Today's High
  • ₹785
  • 52 Week Low
  • ₹262
  • 52 Week High
  • ₹1,037
  • Open Price₹716
  • Previous Close₹735
  • Volume7,000
  • 50 DMA₹730.66
  • 100 DMA₹645.45
  • 200 DMA-

Investment Returns

  • Over 1 Month + 9.18%
  • Over 3 Month -22.45%
  • Over 6 Month + 102.09%
  • Over 1 Year + 441.38%

Smart Investing Starts Here Start SIP with Anondita Medicare for Steady Growth!

Invest Now

Anondita Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 89.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,420
  • P/B Ratio
  • 13.1
  • Average True Range
  • 37.15
  • EPS
  • 8.74
  • Dividend Yield
  • 0
  • MACD Signal
  • -21.9
  • RSI
  • 57.98
  • MFI
  • 38.1

Anondita Medicare Financials

Anondita Medicare Technicals

EMA & SMA

Current Price
₹785.00
+ 50 (6.8%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 12
  • 20 Day
  • ₹723.03
  • 50 Day
  • ₹730.66
  • 100 Day
  • ₹645.45
  • 200 Day
  • -

Resistance and Support

761.93 Pivot Speed
  • R3 877.27
  • R2 831.13
  • R1 808.07
  • S1 738.87
  • S2 692.73
  • S3 669.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Anondita Healthcare manufactures condoms and surgical gloves, supplying India’s family planning and AIDS control programs. With strong government and hospital ties, a growing international presence, and innovations like female condoms, it leads North India’s market under its flagship brand COBRA.

Anondita Medicare Ltd has an operating revenue of Rs. 208.92 Cr. on a trailing 12-month basis. An annual revenue growth of 66% is outstanding, Pre-tax margin of 29% is great, ROE of 41% is exceptional. The company has a reasonable debt to equity of 31%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Anondita Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results

Anondita Medicare F&O

Anondita Medicare Shareholding Pattern

61.79%
4.24%
0.04%
17.12%
16.81%

Anondita Medicare FAQs

Anondita Medicare share price is ₹785 As on 05 April, 2026 | 12:06

The Market Cap of Anondita Medicare is ₹1419.8 Cr As on 05 April, 2026 | 12:06

The P/E ratio of Anondita Medicare is 89.9 As on 05 April, 2026 | 12:06

The PB ratio of Anondita Medicare is 13.1 As on 05 April, 2026 | 12:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23